Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the cardiac arrest survivors with preserved Ejection Fraction Registry.
Krahn AD, Healey JS, Chauhan VS, Birnie DH, Champagne J, Sanatani S, Ahmad K, Ballantyne E, Gerull B, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Klein GJ, Gollob MH, Simpson CS, Talajic M, Gardner M. Krahn AD, et al. Among authors: ballantyne e. Circ Arrhythm Electrophysiol. 2012 Oct;5(5):933-40. doi: 10.1161/CIRCEP.112.973230. Epub 2012 Sep 3. Circ Arrhythm Electrophysiol. 2012. PMID: 22944906
Mutation location effect on severity of phenotype during exercise testing in type 1 long-QT syndrome: impact of transmembrane and C-loop location.
Laksman ZW, Hamilton RM, Chockalingam P, Ballantyne E, Stephenson EA, Gross GJ, Gula LJ, Klein GJ, Wilde AA, Krahn AD. Laksman ZW, et al. Among authors: ballantyne e. J Cardiovasc Electrophysiol. 2013 Sep;24(9):1015-20. doi: 10.1111/jce.12172. Epub 2013 May 20. J Cardiovasc Electrophysiol. 2013. PMID: 23691991
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1).
Simon JA, Anderson RA, Ballantyne E, Bolognese J, Caetano C, Joffe H, Kerr M, Panay N, Seitz C, Seymore S, Trower M, Zuurman L, Pawsey S. Simon JA, et al. Among authors: ballantyne e. Menopause. 2023 Mar 1;30(3):239-246. doi: 10.1097/GME.0000000000002138. Epub 2023 Jan 30. Menopause. 2023. PMID: 36720081 Free PMC article. Clinical Trial.
Meeting sustainable development goals via robotics and autonomous systems.
Guenat S, Purnell P, Davies ZG, Nawrath M, Stringer LC, Babu GR, Balasubramanian M, Ballantyne EEF, Bylappa BK, Chen B, De Jager P, Del Prete A, Di Nuovo A, Ehi-Eromosele CO, Eskandari Torbaghan M, Evans KL, Fraundorfer M, Haouas W, Izunobi JU, Jauregui-Correa JC, Kaddouh BY, Lewycka S, MacIntosh AC, Mady C, Maple C, Mhiret WN, Mohammed-Amin RK, Olawole OC, Oluseyi T, Orfila C, Ossola A, Pfeifer M, Pridmore T, Rijal ML, Rega-Brodsky CC, Robertson ID, Rogers CDF, Rougé C, Rumaney MB, Seeletso MK, Shaqura MZ, Suresh LM, Sweeting MN, Taylor Buck N, Ukwuru MU, Verbeek T, Voss H, Wadud Z, Wang X, Winn N, Dallimer M. Guenat S, et al. Among authors: ballantyne eef. Nat Commun. 2022 Jun 21;13(1):3559. doi: 10.1038/s41467-022-31150-5. Nat Commun. 2022. PMID: 35729171 Free PMC article.
56 results